Abnormal growth factor modulation of β1-integrin-mediated adhesion in chronic myelogenous leukaemia haematopoietic progenitors
- 20 December 2001
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 115 (4) , 845-853
- https://doi.org/10.1046/j.1365-2141.2001.03192.x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores β1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitorsLeukemia, 1998
- BCR/ABL induces multiple abnormalities of cytoskeletal function.Journal of Clinical Investigation, 1997
- Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinaseOncogene, 1997
- P210 and P190 Induce the Tyrosine Phosphorylation and DNA Binding Activity of Multiple Specific STAT Family MembersJournal of Biological Chemistry, 1996
- Bcr/Abl expression stimulates integrin function in hematopoietic cell lines.Journal of Clinical Investigation, 1996
- CRKL Links p210BCR/ABL with Paxillin in Chronic Myelogenous Leukemia CellsJournal of Biological Chemistry, 1995
- Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1 alpha.Journal of Clinical Investigation, 1995
- Integrins: Emerging Paradigms of Signal TransductionAnnual Review of Cell and Developmental Biology, 1995
- Role of bone marrow matrix in normal and abnormal hematopoiesisCritical Reviews in Oncology/Hematology, 1994
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990